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REPLY
In their letter, Drs. Rott and Leibowitz correctly reported the
current indications to myocardial revascularization in type 2
diabetic (DM2) patients, and they concluded that an aggressive
diagnostic approach (like that used in our study) (1) may not be
useful. Unfortunately, they do not take into account that previous
results with percutaneous coronary intervention or aorto-coronary
artery bypass have been obtained applying an old, bankrupt
diagnostic approach to ischemic heart disease (IHD) in DM2
patients. In fact, in the past 20 years, cardiovascular mortality
(mainly due to IHD) increased by 40% to 50% in diabetic patients,
whereas in the same period of observation, major cardiovascular
disease mortality in the nondiabetic population was reduced by
about 30% (2). The poor results of myocardial revascularization
procedures in DM2 patients are largely caused by the extension of
atherosclerotic involvement of coronary artery disease (CAD) at
the moment of diagnosis. The current American Diabetes Asso-
ciation guidelines (3,4) do not allow for the identification of a
population of diabetic patients with a high prevalence of CAD but
only those DM2 patients with advanced atherosclerosis involving
multiple coronary vessels. Similar results may be obtained by
applying the suggestion reported by Drs. Rott and Leibowitz in
their letter: “Noninvasive testing should be performed in asymp-
tomatic diabetics only if clinical assessment suggests that they
belong to a high-risk group.” But all diabetic patients belong to a
high-risk group for cardiovascular mortality!
In an autopsy study, Goraya et al. (5) showed that, among
diabetic decedents without clinical CAD, almost three-fourths had
high-grade atherosclerosis and more than one-half had multivessel
coronary disease. Moreover, Haffner et al. (6) showed that diabetic
patients who have not had a previous myocardial infarction (MI)
have outcomes similar to those of patients without diabetes who
have had a prior MI. In light of these statements we applied to
DM2 patients a diagnostic approach similar to one that is currently
applied in nondiabetic patients with clinical manifestation of
CAD. The diagnostic approach we proposed in our study (1)
allowed us to identify an early phase of CAD in asymptomatic
diabetic patients, and the favorable anatomy of coronary vessels
(with the high prevalence of one-vessel disease) has the potential to
improve results of revascularization procedures and the rate of
cardiac events in asymptomatic diabetic patients.
Finally, in our opinion, we must not be resigned to accept the
current bankrupt diagnostic and therapeutic approach to ischemic
heart disease in diabetic patients, and research into a “New Deal”
is mandatory.
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